| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.066 | 0.7 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |